In vitro studies revealed that recombinant human TGM2 causes a sustained increase in the enzyme activity of recombinant human sPLA2-X identifying a previously unknown mechanism of asthma in which the increase in TGM2 in the airways may function to amplify airway inflammation through eicosanoid generation. Here, TGM2 is linked to asthma.